Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)
Generic Namesort icon Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)
Doravirine + Lamivudine + Tenofovir Delstrigo Antiviral agent 2018/12/15
Doripenem Doribax Antibacterial agent 2009/09
Doxepin Silenor Hypnotic 2012/01/08
Dronabinol Marinol Antiemetic 2012/02/24
Dronedarone Multaq Antiarrhythmic agent 2009/08/14
Drospirenone + estetrol Nextstellis Oral contraceptive 2021/06/15
Drotrecogin alfa Xigris Antithrombotic profibrinolytic anti-inflammatory enzyme 2011/10/25
Dulaglutide Trulicity Antihyperglycemic agent 2016/01/08
Dupilumab Dupixent Skin and mucous membrane agent 2017/11/30
Dutasteride + tamsulosin Jalyn Alpha-1 blocker + 5-Alpha reductase inhibitor 2012/02/03
Eculizumab Soliris Humanized monoclonal antibody 2009/06/29
Edaravone Radicava Treatment for amyotrophic lateral sclerosis 2019/10/29
Edoxaban Lixiana Anticoagulant 2017/01
Elagolix Orilissa Gonadotropin releasing hormone receptor antagonist 2018/10/31
Elbasvir + grazoprevir Zepatier Antiviral agent 2016/02/02
Elexacaftor + tezacaftor + ivacaftor Trikafta Cystic fibrosis transmembrane conductance regulator correctors 2021/06/22
Eltrombopag Revolade Thrombopoietin receptor antagonist 2011/0404
Eluxadoline Viberzi Miscellaneous GI drug 2017/05
Eluxadoline Viberzi Miscellaneous GI drugs 2017/04/24
Elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide Genvoya Antiretroviral agents 2016/02/03
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil fumarate Stribild Antiretroviral agent 2012/12/20
Empagliflozin Jardiance Sodium-glucose contransporter 2 (SGLT2) inhibitor 2015/08/11
Empagliflozin + linagliptin Glyxambi Antidiabetic agent 2016/12/15
Empagliflozin + metformin Synjardy Oral blood glucose lowering agents 2017/09/18
Emtricitabine + tenofovir Descovy Antiretroviral agent 2016/06/03
Enasidenib IDHIFA Antineoplastic agent / IDH2 Inhibitor 2019/02/27
Entrectinib Rozlytrek Antineoplastic agent
Enzalutamide Xtandi Antineoplastic agent 2013/06/07
Eplerenone Inspra Aldosterone antagonist 2009/02/26
Eptinezumab Vyepti Prevention of migraine; calcitonin gene-related peptide binding antibody 2021/01/11
Erdafitinib Balversa Protein kinase inhibitor 2019/12/09
Erenumab Aimovig Anti-calcitonin gene-related peptide receptor 2018/08/01
Eribulin Halaven Antineoplastic agent 2012/03/10
Ertugliflozin Steglatro Sodium-glucose co-transporter 2 (SGLT2) inhibitor 2018/05/23
Ertugliflozin + metformin Segluromet Oral blood glucose lowering agents 2018/05/30
Ertugliflozin + sitagliptin Steglujan Oral blood glucose lowering agents 2018/05/22
Syndicate content